Novavax completes process for WHO emergency use approval of COVID-19 vaccine

  • 📰 YahooSG
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The company submitted to the health agency all modules required for the evaluation of NVX-CoV2373, its protein-based COVID-19 vaccine, days after receiving its first emergency use authorisation from Indonesia.

FILE PHOTO: A woman holds a small bottle labeled with a"Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration -Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.

"The first authorization of the COVID-19 vaccine... will fill a vital need for Indonesia, which is the fourth most populous nation on earth and continues to work to procure sufficient vaccine for its population," Chief Executive Stanley Erck said during an investor call. A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries.

"We expect the need for boosters will continue in the coming years," he said. "Over the coming months, we will be able to support supply to additional markets in need of boosters."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19: UK approves Merck’s molnupiravir, making it the first pill endorsed for treatmentBritain on Thursday (Nov 4) approved the antiviral drug molnupiravir for treating the coronavirus, making it the first pill to be endorsed for Covid patients. 哇哦
Source: TODAYonline - 🏆 1. / 99 Read more »

India's first homegrown COVID-19 shot wins WHO emergency use listingThe World Health Organization (WHO) on Wednesday said it had approved Indian drugmaker Bharat Biotech's COVID-19 vaccine for emergency use, paving the way for the homegrown shot to be accepted as a valid vaccine in many poor countries. The emergency use listing would allow Bharat Biotech to ship the shot known as Covaxin to countries that rely on WHO guidance for their regulatory decisions. The WHO tweet its technical advisory group had ruled that Covaxin's benefits significantly outweighed the risks and that it met WHO standards for protection against COVID-19.
Source: YahooSG - 🏆 3. / 71 Read more »

Gough won't umpire T20 World Cup games after COVID-19 breach - ICCEnglish umpire Michael Gough will not officiate any more games in the Twenty20 World Cup after he broke COVID-19 health protocols during the tournament, the International Cricket Council said on Wednesday.The 41-year-old Gough was withdrawn from umpiring New Zealand's Super 12 match against India on Sunda
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Singapore reports 3,635 new COVID-19 cases, 12 more deathsSINGAPORE: Singapore reported 3,635 new COVID-19 cases as of noon on Wednesday (Nov 3) as 12 more people died from complications due to the coronavirus. The fatalities were aged between 59 and 99. All of them had various underlying medical conditions. The Ministry of Health (M Some one said if infection growth rate falls below 1, may... 3500+ case a day and you want to ease some measures? More vaccinated peoples can dine-out in a group of 4 or 5 or more? What was the % of vaccinated of 3500 peoples infected? Still open? What if rate 1 again?
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »